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Objective: To compare the CT colonography (CTC) and double-contrast barium enema (DCBE) for colonic evaluation in 
patients with renal insufficiency.
Materials and Methods: Two sequential groups of consecutive patients with renal insufficiency who had a similar risk for 
colorectal cancer, were examined by DCBE (n = 182; mean ± SD in age, 51 ± 6.4 years) and CTC (n = 176; 50 ± 6.7 years), 
respectively. CTC was performed after colon cleansing with 250-mL magnesium citrate (n = 87) or 4-L polyethylene glycol (n 
= 89) and fecal tagging. DCBE was performed after preparation with 250-mL magnesium citrate. Patients with colonic 
polyps/masses of ≥ 6 mm were subsequently recommended to undergo a colonoscopy. Diagnostic yield and positive 
predictive value (PPV) for colonic polyps/masses, examination quality, and examination-related serum electrolyte change 
were retrospectively compared between the two groups.
Results: Both the CTC and DCBE were positive for colonic polyps/masses in 28 (16%) of 176 and 11 (6%) of 182 patients, 
respectively (p = 0.004). Among patients with positive findings, 17 CTC and six DCBE patients subsequently underwent a 
colonoscopy and yielded a PPV of 88% (15 of 17 patients) and 50% (3 of 6 patients), respectively (p = 0.089). Thirteen 
patients with adenomatous lesions were detected in the CTC group (adenocarcinoma [n = 1], advanced adenoma [n = 6], 
and non-advanced adenoma [n = 6]), as compared with two patients (each with adenocarcinoma and advanced adenoma) 
in the DCBE group (p = 0.003). Six (3%) of 176 CTC and 16 (9%) of 182 DCBE examinations deemed to be inadequate (p = 
0.046). Electrolyte changes were similar in the two groups.
Conclusion: In patients with renal insufficiency, CTC has a higher diagnostic yield and a marginally higher PPV for detecting 
colorectal neoplasia, despite a similar diagnostic yield for adenocarcinoma, and a lower rate of inadequate examinations as 
compared with DCBE.
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INTRODUCTION
Colonic evaluation for screening of colorectal neoplasms 
and diverticular diseases is generally a routine procedure 
before renal transplantation for end-stage renal disease 
(ESRD). ESRD has been associated with increased risks of 
malignancy and immunosuppressive therapy after renal 
transplantation may increase the risk of malignancy or 
accelerate the malignant progression of neoplasia, although 
their effects specifically on colorectal cancer still need 
http://dx.doi.org/10.3348/kjr.2012.13.3.290
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to be further clarified (1-10). In addition, patients with 
diverticula/diverticulitis may be at higher risk of colonic 
perforation after renal transplantation, since immune 
suppression may mask the signs and symptoms of post-
transplant diverticulitis, hence delaying diagnosis and 
increasing the risk of perforation (11-13).
Many patients with ESRD undergo a period of peritoneal 
dialysis before renal transplantation. Thus, radiological 
colonic examinations may be particularly useful for those 
who have developed peritoneal adhesion after dialysis, 
which could make colonoscopy difficult. Among the 
radiological colonic examinations, CT colonography (CTC) 
is particularly expected to be suitable for examining ESRD 
patients compared to double-contrast barium enema (DCBE). 
Unlike DCBE, CTC can be performed following a “wet” bowel 
preparation with polyethylene glycol (PEG) (14), the safest 
cathartic agent for ESRD patients (15, 16). CTC may also 
be able to potentially remove the risk of fluid/electrolyte 
disturbance in ESRD patients, adopting catharsis-free 
techniques. To our knowledge, no studies have compared 
CTC to DCBE in patients with renal insufficiency. In addition, 
although CTC is generally regarded to be more accurate 
diagnostically than DCBE, to date, there have been few 
direct comparisons of CTC and DCBE, and with the studies 
performed being before CTC techniques were optimized (17, 
18). Therefore, the purpose of this study was to compare 
the CTC and DCBE for colonic evaluation in patients with 
renal insufficiency.
MATERIALS AND METHODS 
The study was in accordance with the ethical standards 
of Declaration of Helsinki. The institutional review board of 
Asan Medical Center approved this retrospective study and 
waived patient informed consent.
Study Patients
At our institution, colorectal screening for neoplasms 
and diverticular diseases is a routine part of the diagnostic 
work-up prior to renal transplantation in patients older than 
40 years. We used the DCBE until January 2008, and we 
then switched over to the CTC. Our study cohort consisted 
of 182 consecutive ESRD patients (109 men and 73 women; 
mean ± SD age, 50.9 ± 6.4 years) who underwent DCBE 
for pretransplant evaluation between January 2006 and 
December 2007, and 176 consecutive ESRD patients (101 
men and 75 women; mean ± SD age, 49.6 ± 6.7 years) who 
underwent CTC between January 2008 and December 2009. 
Review of Medical Records
We reviewed the history of colorectal cancer, colorectal 
adenoma, polyposis, inflammatory bowel disease, and 
hereditary nonpolyposis colorectal cancer syndrome of all 
patients and their family (including parents, siblings, and/
or children) history of colorectal cancer. We additionally 
assessed patients’ colorectal symptoms, including any 
changes in bowel habits and blood in stool. We also 
reviewed the CTC, DCBE, and colonoscopy results of all 
patients and their serum concentrations of sodium, 
potassium, calcium, and creatinine prior to and after the 
CTC and DCBE. The occurrence of any adverse events related 
to a CTC and DCBE was confirmed.
CTC Examination
Bowel preparation for a CTC consisted of two different 
protocols. All patients ingested a clear liquid diet the 
day before a CTC and underwent a cathartic preparation 
the night before the examination. The first 87 patients 
ingested 250 mL magnesium citrate (Magcorol; Taejoon 
Pharmaceuticals, Gyeonggido, Korea) and 10 mg bisacodyl 
for colon cleansing. Fecal tagging in these patients 
consisted of 200 mL of a 4.6% wt/vol barium suspension 
(Easy CT 4.6; Taejoon Pharmaceuticals, Gyeonggido, 
Korea) (19), taken after each meal the day before CTC (i.e. 
three doses for a total to 600 mL). Due to the occasional 
occurrence of a large amount of untagged stool with the 
magnesium citrate preparation and the reported higher 
safety of PEG in patients with renal insufficiency (15), 
the following 89 patients underwent bowel preparation 
by ingesting 4 L PEG (Colyte; Taejoon Pharmaceuticals, 
Gyeonggido, Korea). Fluid tagging in these patients 
consisted of 50 mL meglumine diatrizoate (Gastrografin; 
Bayer Schering Pharma AG, Berlin, Germany) ingested orally 
after a colon cleansing.
Colonic distention before CT scanning was performed 
using an automated carbon dioxide insufflator (PROTOCO2L; 
Bracco, Milan, Italy); spasmolytics were not used. Each 
patient underwent both supine and prone scans, performed 
using a 16-MDCT scanner (Somatom Sensation 16; 
Siemens Medical Solutions, Erlangen, Germany) with the 
following specifications: collimation, 0.75 mm x 16; pitch, 
1; reconstructed slice thickness, 1 mm; reconstruction 
interval, 0.7 mm; field of view to fit; 120 kVp; and 50 mAs. 
Intravenous contrast was not administered.Korean J Radiol 13(3), May/Jun 2012 kjronline.org 292
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The original clinical interpretations of the CTC results 
were used for this study and the results were interpreted 
by one of two board-certified experienced radiologists 
(S.H.P. and S.S.L., each of whom had interpreted more than 
1000 CTC cases at the beginning of the study period). CTC 
results were interpreted primarily using three-dimensional 
(3D) endoluminal navigation with two-dimensional (2D) 
problem solving at a dedicated CTC workstation (Xelis 
Colon; Infinitt, Seoul, Korea) (20). Technical assessments, 
including adequacy of bowel preparation, fecal and fluid 
tagging, colonic distention, and CT artifacts, were made on 
a per-patient basis according to the CTC Reporting and Data 
System (C-RADS) (21). Inadequate examinations (C0), in 
which the radiologist was unable to exclude the presence 
of polyps ≥ 1 cm in maximal diameter, were recorded, along 
with the cause of each problem. Colonic masses and polyps 
≥ 6 mm in maximal diameter and colonic diverticula or 
diverticulitis were reported. The segmental location and 
morphology (sessile, pedunculated, or flat) of the colonic 
mass/polyp were recorded. Extracolonic evaluation was 
performed as usual and also included confirmation of the 
absence/presence of any abnormal findings in the iliac 
fossae in which the transplanted kidney was intended to 
be placed. Any examination-related adverse reactions and 
complications were recorded.
Data on radiation dose were collected in each patient 
from the dose table provided by the scanner and 
were converted to an effective dose according to the 
International Commission on Radiological Protection 
publication 103 recommendations (22).
DCBE Examination
All patients ingested a clear liquid diet the day before 
a DCBE. A colon cleansing was performed by the oral 
ingestion of 250 mL magnesium citrate and 10 mg bisacodyl 
the night before the examination. PEG was not used as it 
leaves excess fluid in the colon and impairs mucosal barium 
coating (16). A DCBE was performed by first- or second-year 
radiology residents according to standard techniques (16) 
using digital fluoroscopic equipment (Shimavision 3200 HG; 
Shimadzu, Kyoto, Japan) and a transrectally administered 
400 to 600 mL of 80% wt/vol barium suspension (Solotop 
Powder; Taejoon Pharmaceuticals, Gyeonggido, Korea). The 
original clinical interpretations of DCBE results were used 
for this study. DCBE results were interpreted in consensus 
by a junior instructor in gastrointestinal radiology and 
the resident who had performed the examination. The 
findings were reported in the same way as those of CTC. 
Radiation dose information was not available for the DCBE 
examinations.
 
Colonoscopy
 The need for a colonoscopy following CTC or DCBE 
was ultimately determined by the referring clinicians, 
who considered the sizes of colonic lesions and the 
ability of the patient to undergo renal transplantation. A 
colonoscopy was performed by experienced board-certified 
gastroenterologists using a video colonoscope (CF 260; 
Olympus Optical Co., Tokyo, Japan). The colonoscopists had 
been informed of the CTC or DCBE results prior to performing 
the colonoscopy. Segmental location, size, and morphology 
of the detected lesions were recorded, and the lesions were 
removed or biopsied for pathologic examination. Lesion 
matching between CTC or DCBE and colonoscopy required 
both segmental and size agreement (i.e. within the same 
or adjacent segment and within ± 50% of the colonoscopic 
size) (23, 24). The results of colonoscopy served as the 
reference standard for the colonic masses/polyps.
Data and Statistical Analysis
In order to confirm the comparability between the CTC 
and DCBE groups (i.e. similar risk for colorectal cancer/
neoplasia), we compared the demographic and clinical 
characteristics (i.e., age, sex distribution, and risk factors 
for colorectal cancers). As our retrospective clinical 
patients did not undergo subsequent colonoscopy if their 
CTC or DCBE had been negative, we could not calculate 
sensitivity and specificity. We instead focused primarily on 
analyzing the diagnostic yield of the CTC and DCBE, which 
is a well established method to compare diagnostic tests 
in a retrospective setting (25). The diagnostic yield is 
also a higher level index of clinical impact of a diagnostic 
test than sensitivity/specificity in the hierarchy of health 
technology assessment (26). We calculated the positive test 
rate, positive predictive value (PPV), and diagnostic yield 
of CTC and DCBE for colonic masses/polyps on a per-patient 
basis and compared the results of each parameter between 
the two groups. For the per-patient PPV, at least one 
relevant match between the CTC or DCBE and colonoscopy 
was required to be considered a true-positive examination. 
Positive test rate and PPV were calculated for two lesion 
size thresholds: ≥ 6 mm and ≥ 10 mm in maximal diameter. 
Diagnostic yields were obtained for three histological 
categories: all types of adenomatous lesions, advanced Korean J Radiol 13(3), May/Jun 2012 kjronline.org 293
CT Colonography and Double-Contrast Barium Enema in Patients with Renal Insufficiency
neoplasia, and adenocarcinoma. Advanced neoplasia 
represented both advanced adenomas (defined as adenomas 
≥ 10 mm or by the presence of a substantial villous 
component or high-grade dysplasia) and adenocarcinomas. 
For the per-patient analysis of diagnostic yields, patients 
were categorized according to their most significant 
colonic lesion histology, regardless of the presence and 
the number of colonic lesions of less important histology 
(adenocarcinoma, advanced adenoma, non-advanced 
adenoma, and non-adenomatous lesions in decreasing order 
of importance). 
The rates of diverticular diseases and clinically suspicious 
extracolonic findings for CTC and DCBE (i.e. extracolonic 
findings which were interpreted to require further diagnostic 
evaluation or treatment) were compared, as was the rate of 
inadequate quality examinations. We also compared changes 
in serum concentrations for electrolytes and creatinine if 
they had been measured prior to (within seven days) and 
after (either the same or the next day) the cathartic bowel 
preparation, among the DCBE and CTC patients prepared 
with magnesium citrate and CTC patients prepared with PEG.
Categorical variables of the CTC and DCBE groups were 
compared using Fisher’s exact test, and continuous variables 
using Student t test. Comparisons among the three groups 
(DCBE patients and the two groups of CTC patients) were 
made using analysis of variance. Statistical analyses were 
performed with SPSS 15.0 for Windows (SPSS, Chicago, IL). 
p values less than 0.05 were considered to be statistically 
significant.
RESULTS
Patient Characteristics
The demographic characteristics and colorectal 
cancer risks of patients in the CTC and DCBE groups are 
summarized in Table 1. There were no significant between 
group differences for gender and the known risk factors 
for colorectal cancer. Although the age difference was not 
statistically significanct (p = 0.053), the average age of 
DCBE patients was approximately 1 year older than the 
average age of CTC patients.
 
Colonic and Extracolonic Findings
The outcomes regarding colonic masses/polyps of patients 
who underwent a CTC and DCBE are summarized in Figure 
1. The CTC had a significantly higher positive test rate than 
did the DCBE for lesions ≥ 6 mm (15.9% [28/176] vs. 6% 
[11/182]; p = 0.004), but not for lesions ≥ 10 mm (5.1% 
[9/176] vs. 3.8% [7/182]; p = 0.616).
Colonoscopic follow-up results were available in 17 of 
the 28 patients (60.7%) with positive CTC findings (i.e. 
lesions ≥ 6 mm), and a median time interval between 
the two examinations of 16 days (range, 1 to 165 days), 
and in 6 of the 11 patients (54.5%) with positive DCBE 
findings with a median time interval of 21 days (range, 11 
to 69 days) (p = 0.734). Of the other 16 patients whose 
colonoscopic follow-up results were not available, 12 were 
lost to follow-up without subsequent colonoscopy as they 
finally declined or were denied a renal transplantation, 
and 4 did not undergo a colonoscopy most likely due to a 
small lesion size (Fig. 1). Colonoscopy results showed that 
PPVs for the CTCs and DCBEs were 88.2% (15/17) and 50% 
(3/6), respectively for detecting ≥ 6 mm lesions (p = 0.089); 
and were 100% (6/6 patients) and 50% (2/4 patients) for 
detecting lesions ≥ 10 mm (p = 0.133), indicating a trend 
that the CTC shows a higher PPV, albeit not statistically 
significant. The 17 patients who underwent a colonoscopy 
following positive CTC results turned out to be patients 
with adenocarcinoma (n = 1) (Fig. 2), advanced adenoma 
(n = 6), non-advanced adenoma (n = 6), non-adenomatous 
lesion (n = 2), and false-positive findings (n = 2). Both of 
the latter two false-positive patients underwent a colon 
preparation with magnesium citrate. The six patients who 
underwent colonoscopy following positive DCBE results 
turned out to be patients with adenocarcinoma (n = 1) (Fig. 
3), advanced adenoma (n = 1), nonadenomatous lesion (n = 
1), and false-positive findings (n = 3). The diagnostic yields 
relative to histological categories for both the CTC and DCBE 
Table 1. Characteristics of Study Patients
CTC
(n = 176)
DCBE
(n = 182)
P Value
Age, mean ± SD (yrs) 49.6 ± 6.7 50.9 ± 6.4 0.053
Sex (male : female) 101 : 75 109 : 73 0.668
Family history of  
  colorectal cancer
3 3 1
History of related  
  diseases*
1
† 1
† 1
Colorectal symptoms
‡ 0 0 1
Note.— Data are number of patients except for age. 
*History of colorectal cancer, colorectal adenoma, polyposis, 
inflammatory bowel disease, or hereditary nonpolyposis 
colorectal cancer syndrome, 
†History of polypectomy of tubular 
adenoma, 
‡Changes in bowel habits and blood in stool.
CTC = CT colonography, DCBE = double-contrast barium enemaKorean J Radiol 13(3), May/Jun 2012 kjronline.org 294
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are summarized in Table 2. CTC had a significantly higher 
diagnostic yield than DCBE for all adenomatous lesions (p 
= 0.003), and showed a trend for higher yield in advanced 
neoplasias, although not statistically significant (p = 0.099).
Forty-four of 176 (25%) CTC patients (all without 
diverticulitis) and 41 of 182 (22.5%) DCBE patients (40 
without and one with diverticulitis) had diverticular 
diseases, with no significant between group difference (p = 
0.620).
Suspicious extracolonic abnormalities were noted in 14 
of 176 (8.0%) CTC patients; of these, 11 were confirmed 
as true positive and one turned out to be a pseudolesion 
in the kidney at follow-up evaluations (4 benign 
pulmonary nodules, 1 pneumothorax, 1 gallbladder stone, 
1 pancreatic cystic neoplasm, 1 chronic pancreatitis, 1 
splenic hemangioma, 1 ovarian teratoma, and 1 benign 
lymphadenopathy). The remaining two patients, who had 
a suspected lymphadenopathy and a peritoneal nodule, 
respectively, have not been further characterized. Notable 
extracolonic findings were observed in only 2 of 182 DCBE 
patients (1.1%) (p < 0.001 compared with CTC), which 
were an extrinsic colon compression, suggesting that pelvic 
masses were present in both patients, but confirmed as 
false positive. Detection of the exracolonic findings did 
not affect renal transplantation in any patient but caused 
treatment in the patient with pneumothorax and interval 
clinical follow-ups in one each with a gallbladder stone, 
pancreatic cystic neoplasm, and chronic pancreatitis.
Examination Quality
Examination quality was inadequate in 6 of the 176 
CTC patients (3.4%) and 16 of the 182 DCBE patients 
(8.8%) (p = 0.046). In these patients, the presence of 
large advanced cancer masses such as “apple-core” lesions 
and large ulcerofungating masses could be excluded, but 
smaller lesions could not be excluded. Causes of inadequate 
examinations in the CTC group include large amounts of 
untagged stool in 3 patients, all of which were prepared 
with magnesium citrate; collapse of the sigmoid colon 
in 2; and a respiratory motion artifact in 1. In the DCBE 
group, all inadequate examinations were due to poor bowel 
preparation and poor mucosal coating.
Fig. 1. Enrollment and outcomes of patients undergoing CTC and DCBE. 
A. Patients undergoing a CTC. *Positive for colonic masses/polyps ≥ 6 mm in size, 
†Seven patients were lost to follow-up without subsequent 
colonoscopy as they finally declined or were denied renal transplantation, and four patients did not undergo colonoscopy, most likely due to 
small lesion size. B. Patients undergoing DCBE. *Positive for colonic masses/polyps ≥ 6 mm in size, 
†Patients were lost to follow-up without 
subsequent colonoscopy as they finally declined or were denied to undergo renal transplantation. CTC = CT colonography, DCBE = double-
contrast barium enema
A B
CTC study patients
n = 176
Patients with positive
colonic findings*
n = 28
Subsequent 
colonoscopy 
performed
n = 6
True positive 
patients
n = 6
Patients with 
adenocarcinoma (n = 1)
advanced adenoma (n = 4)
non-adenomatous lesion (n = 1)
Patients with 
adenocarcinoma (n = 2)
non-advanced adenoma (n = 6)
non-adenomatous lesion (n = 1)
True positive 
patients
n = 9
False positive 
patients
n = 0
False positive 
patients
n = 2
Subsequent 
colonoscopy 
performed
n = 11
Subsequent 
colonoscopy 
not performed
†
n = 3
Subsequent 
colonoscopy 
not performed
†
n = 8
Patients with lesions ≥ 10 mm
n = 9
Patients with lesions 6-9 mm
n = 19
Patients with negative
colonic findings*
n = 148
DCBE study patients
n = 182
Patients with positive
colonic findings*
n = 11
Subsequent 
colonoscopy 
performed
n = 4
True positive 
patients
n = 2
Patients with 
adenocarcinoma (n = 1)
advanced adenoma (n = 1)
Patients with 
non-adenomatous lesion (n = 1)
True positive 
patients
n = 1
False positive 
patients
n = 2
False positive 
patients
n = 1
Subsequent 
colonoscopy 
performed
n = 2
Subsequent 
colonoscopy 
not performed
†
n = 3
Subsequent 
colonoscopy 
not performed
†
n = 2
Patients with lesions ≥ 10 mm
n = 7
Patients with lesions 6-9 mm
n = 4
Patients with negative
colonic findings*
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Laboratory Data and Adverse Effects
Serum concentrations of electrolytes and creatinine 
were not routinely measured before and after colonic 
examinations, since the safety of our bowel preparation 
methods was generally known. At the discretion of the 
attending physicians, electrolytes and creatinine were 
measured both before (within seven days) and after (either 
the same or the next day) colonic examinations in 27 
DCBE patients, 38 CTC patients prepared with magnesium 
citrate, and 33 CTC patients prepared with PEG (Table 3). 
Changes in serum Na, K, Ca, and creatinine were all minimal 
and clinically insignificant in all three groups and did not 
differ significantly among groups (p ≥ 0.157), except for 
serum Na where CTC patients prepared with PEG showed 
greater change than the two other groups (p = 0.001). No 
patient had a serum electrolyte and/or fluid imbalance that 
required urgent treatment.
All patients tolerated the examination well and there 
were no cases of colonic perforation or other significant 
complications related to CTC or DCBE.
 
Radiation Dose
The mean ± SD effective CTC dose for the combined 
supine and prone scans was 4.8 ± 0.4 mSv for male patients 
and 6.6 ± 0.4 mSv for female patients.
A B C
Fig. 2. 15-mm adenocarcinoma in sigmoid colon of 55-year-old man detected by CTC. CTC also detected another 9-mm cancerous 
polyp (not shown).
A. 3D endoluminal image of CTC showing rounded polyp in sigmoid colon (arrow). White curvilinear area (arrowheads) represents tagged fluid 
around polyp. B. Sagittal 2D CTC image showing polyp (arrow) and tagged fluid (arrowheads) adjacent to lesion. C. Colonoscopy performed next 
day showing corresponding 15-mm polyp. CTC = CT colonography
A B C
Fig. 3. Two 25-mm and 20-mm adenocarcinomas in sigmoid colon of 65-year-old man detected by DCBE.
A. DCBE image of sigmoid colon showing two polypoid masses (arrows). B, C. Colonoscopy performed three weeks after DCBE showing 25-mm 
polypoid mass with ulceration in sigmoid colon (B) and another 20-mm polypoid mass located more proximally (C). DCBE = double-contrast 
barium enemaKorean J Radiol 13(3), May/Jun 2012 kjronline.org 296
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DISCUSSION
We observed that CTC had a higher diagnostic yield 
than DCBE for detecting colorectal neoplasia in ESRD 
patients, which was consistent with the generally regarded 
superior diagnostic accuracy of CTC compared to DCBE 
(27), and that the methods had a similar ability to detect 
diverticular diseases. These results may suggest that 
CTC is diagnostically superior to DCBE for pretransplant 
colorectal screening of ESRD patients. However, the greater 
resources are needed for the CTC compared to DCBE and the 
superiority of the CTC in our study was mostly attributed 
to the better detection of small non-cancerous lesions by 
CTCs, which are less of an immediate clinical concern. The 
difference was absent for adenocarcinoma and was only 
marginal for advanced neoplasia. Therefore, our results may 
not necessarily indicate that the CTC is a more cost-effective 
screening method for ESRD patients. In fact, the DCBE 
was shown to have reasonably high accuracy for detecting 
colorectal cancers approaching the lower-range performance 
of colonoscopy even though it is inferior in overall polyp 
detection (28-30). There was also some uncertainty in 
our study related to the lack of colonoscopy confirmation 
in some of the CTC- and DCBE-positive patients. Hence, 
the diagnostic yields of the two tests could be somewhat 
inaccurate. Since DCBEs had seemingly a lower PPV (50%) 
than CTCs (88.2% and 100% depending on lesion size), the 
difference in diagnostic yield between the two examinations 
might have been slightly greater if all patients positive on 
these examinations had undergone colonoscopy. 
The overall superior diagnostic yield of CTCs for detecting 
colorectal neoplasia may be due to several factors. First, 
although direct comparative studies of CTCs and DCBEs 
are scarce (17, 18), CTCs may have a higher intrinsic 
diagnostic accuracy than DCBEs, as demonstrated by prior 
indirect comparisons (27). Second, CTCs were performed 
by experienced board-certified radiologists, whereas DCBEs 
were performed by relatively less experienced personnel 
(first- and second-year residents and a junior instructor). 
If DCBEs had been performed, they interpreted by more 
experienced practitioners and may have resulted in a 
higher diagnostic yield and PPV. However, our practice 
pattern reflects the current trend of declining quality of 
DCBEs at many institutions, due to examinations being 
performed by individuals with insufficient experience (31, 
32). As referring clinicians increasingly dismiss DCBEs, 
many institutions do not have a large enough case volume 
for resident trainees to master the needed skills and for 
supervisors to maintain their expertise (33, 34). Third, the 
inferior results for DCBEs may be due in part to the less 
complete bowel cleansing in the DCBE group due to the 
use of moderate amounts of magnesium citrate, (i.e. 250 
mL). This is reflected by the higher rates of technically 
inadequate (8.8%) and false-positive (50%) examinations 
for the DCBE group compared to the CTC group. Likewise, 
in the CTC group, all false-positive patients (n = 2) and 
patients with poor bowel preparation (n = 3) had been 
prepared with magnesium citrate. Magnesium citrate has 
a less potent cathartic effect than sodium phosphate or 
PEG, and a double dose of magnesium citrate (592 mL) was 
required to achieve the same level of colon cleansing as 45 
mL of sodium phosphate in one study (35). Nevertheless, 
we only used a moderate amount of magnesium citrate 
in our patients, since it should be used with caution in 
patients with renal impairment, even if it is safer than 
sodium phosphate, which should not be used in patients 
with decreased renal function (15, 36-39). Our results 
showed that this moderate amount of magnesium citrate 
did not cause any greater changes in electrolytes than PEG 
or any substantial electrolyte imbalance. 
The ability to perform a CTC with PEG is an advantage 
of this method for patients with renal impairment, as 
PEG is a potent and yet known to be the safest cathartic 
agent that causes the least fluid/electrolyte disturbance. 
PEG cannot be used for DCBE due to the large amount of 
retained fluid, which prevents mucosal coating, unless 
Table 2. Diagnostic Yields of CTC and DCBE
CTC
(n = 176)
DCBE
(n = 182)
P Value
Patients with positive 
  test results*
28 (15.9) 11 (6.0) 0.004
Patients with all types  
  of adenomatous lesions
13 (7.4) 2 (1.1) 0.003
Patients with advanced  
  neoplasia
7 (4.0) 2 (1.1) 0.099
Patients with  
  adenocarcinoma
1 (0.6) 1 (0.5) 1.000
Note.— Data are number of patients, with percentage in 
parentheses. *Positive tests were defined as presence of 
colonic polyps/masses ≥ 6 mm in diameter. Colonoscopic 
follow-up was performed in 17 of 28 patients (60.7%) with 
positive CTC findings and six of 11 (54.5%) with positive DCBE 
findings (p = 0.734). CTC = CT colonography, DCBE = double-
contrast barium enemaKorean J Radiol 13(3), May/Jun 2012 kjronline.org 297
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the procedure incorporates a delay of at least 12-18 hours 
and an additional administration of stimulant cathartics 
(16, 40). Interestingly enough, however, the only notable 
serum electrolyte change in our study, albeit clinically 
insignificant, occurred in patients prepared with PEG. 
Considering the well-established safety profile of PEG, the 
unexpected greater degree of elevation in serum Na in 
patients prepared with PEG might have been related to the 
use of Gastrografin for fluid tagging in the same group of 
patients, although it is a conjecture. Hypovolemia and/
or electrolyte imbalance caused by Gastrografin-induced 
fluid loss from the intestine is a well-known adverse effect 
of Gastrografin and, therefore, its administration should 
be done with caution in patients with renal impairment 
who are at high risk for fluid/electrolyte imbalance (41). 
Our results suggest that the oral administration of 50 mL 
Gastrografin for fluid tagging in CTC is likely tolerable 
without any clinical consequences in ESRD patients. 
Nevertheless, the potential adverse effects of Gastrografin 
in patients with renal impairment may need to be further 
clarified. Additionally, as the ingestion of 4 L PEG is quite 
burdensome for patients, efforts are being made to decrease 
the volume of the cathartics and it may be worthwhile to 
investigate if CTC could be performed successfully with a 
smaller volume of PEG in patients with renal insufficiency.
A CTC may have several other potential advantages 
over DCBE; it allows for the seamless continuation to 
colonoscopy in cases where a colonoscopic polypectomy 
or biopsy is required. In contrast, colonoscopy has 
to be delayed after a DCBE, until the instilled barium 
is evacuated. Extracolonic evaluation of CTC has also 
been reported to detect a considerable number of 
clinically important extracolonic abnormalities, including 
malignancies, which would not be detectable with a DCBE, 
even though our CTC patients happened not to have any 
extracolonic malignancies or abnormalities that would 
have precluded renal transplantation. Moreover, radiation 
exposure caused by a CTC in our study was a bit lower than 
or at the lower margin of the radiation exposure from the 
radiation exposure from a DCBE reported in the literature (5 
to 9 mSv) (42).
Our study had several limitations. First, as we did not 
randomize the patients for undergoing either a CTC or a 
DCBE, there may have been the potential for a selection 
bias, leading to a difference in prevalence for colorectal 
neoplasia in the CTC and DCBE groups. However, the 
potential bias may have been negligible as the groups 
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were similar in several main known risk factors for 
colorectal cancer. In fact, considering that the DCBE group 
consisted of slightly older patients than the CTC group, 
the bias, if any, may have existed for a slightly higher 
prevalence of colorectal neoplasia in the DCBE group. 
Second, as mentioned previously, our study with the 
retrospective clinical population could not directly address 
the comparative sensitivity and specificity of DCBE and 
CTC. However, comparing the diagnostic yields is also a 
well established method to compare the clinical impact of 
diagnostic tests (25, 26). Third, as our study population 
only included ESRD patients, it is unclear if our results can 
be extrapolated to a general comparison of a CTC and a 
DCBE. A DCBE may perform better in patients without renal 
impairment, following more vigorous bowel cleansing and 
using a larger amount of magnesium citrate.
In conclusion, the CTC showed a higher diagnostic 
yield and a marginally higher PPV for detecting colorectal 
neoplasia, despite a similar diagnostic yield for 
adenocarcinoma, compared with a DCBE in patients with 
renal insufficiency. In addition, the two methods were 
similar in detecting diverticular diseases, and CTC had a 
lower rate of inadequate examinations than DCBE.
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